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1. Introduction 
Post-translational modification (PTM), the chemical modification of a protein after its 
translation, represents an evolutionarily conserved mechanism of regulation of protein 
function. (Deribe et al., 2010) Through modulation of conformational change, enzymatic 
activity or interaction with other proteins, it often provides a transient switch between 
various intracellular signals to orchestrate an integrated response of the cell to 
environmental cues.  
Site-directed mutagenesis has proven to be an essential tool in studying the molecular and 
signaling mechanisms of complex cellular functions through the ability to mutate a specific 
residue in the sequence of native protein in order to change its function. In combination 
with proteomics and database analysis of primary sequences, it offers a tool for exploring 
the transient nature of protein-protein interactions along with activity of enzymes, the 
primary assemblies of signaling nodes. 
This chapter will highlight the use of site-directed mutagenesis for studying signal 
transduction networks. It will first describe how the diversity of the natural 22 amino acid 
‘toolbelt’ results in fortuitous isostructural and isoelectronic similarity to several key post-
translationally modifications (e.g. phosphorylation, sulfoxidation and nitrosylation). This 
similarity has allowed researchers to introduce gain- or loss-of-function substitutions into 
primary sequences and thus produce a form of the protein that mimicks its active or inactive 
state. The substitution of serine or threonine for phosphomimetic aspartic or glutamic acid 
or non-phosphorylatable residues, such as alanine, will be discussed, along with other 
permutations, including natural analogs of oxidized methionine and cysteine.  
While discussing how site-directed mutagenesis offers to researchers a tool to engineer a 
constitutively active OFF and ON forms of a protein, we will also provide examples of how 
PTM translates into a chemical phenotype through the regulation of enzyme activity or 
modulation of binding affinity to partners. Also discussed in this chapter are limitations and 
considerations to be taken when interpreting results obtained with biomimetic tools. 
With advanced computing analysis and algorithms operating on primary sequences, the 
predictability of PTM sites is rapidly becoming an automated process. Complex networks 
can be accessed and verified. Even in the age of high-resolution mass spectrometry, site-
directed mutagenesis will continue to be a powerful tool for studying and validation of 
signaling networks. 
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2. Harnessing nature’s toolbelt with biomimetic point mutations 
Site-directed mutagenesis, a molecular biology technique used to introduce a point mutation 
into primary DNA sequence at a defined site, was first described by Michael Smith in 1978. 
(Hutchison et al, 1978) His group induced specific mutations into the viral DNA strand of 
the bacteriophage phiX174 am3 using complementary oligodeoxyribonucleotides and 
specific mutagens. “It appears to us that general methods for the construction of any desired 
mutant sequence would greatly increase the ability of sequencing methods to yield 
biologically relevant information. Such methods should also make it possible to construct 
DNAs with specific modified biological functions” M. Smith and his colleagues proposed in 
the paper. This was proven to be correct by vast number of studies, which exploited site-
directed mutagenesis as a tool for testing structure-function relationships over the course of 
three decades. Providing a constitutively activated or deactivated form of the protein or 
removing entirely the potential for protein modification, it has also been instrumental in 
dissecting signal transduction networks. It is instructive to understand the precise strengths 
and limitations of biomimetic approaches in order to extract the most meaningful data from 
experiments. 
2.1 Layers of diversity 
The quest to understand and control structure-function relationship has revealed that 
Nature is an exquisite chemist. The already significant chemical diversity of the amino acid 
pool is amplified profoundly when individual amino acids are condensed into peptide 
chains. Individual residues can act in a seemingly modular fashion, or residues can 
coordinate to bestow more complex and macroscopic functional and catalytic characteristics 
to the proteins and peptides on which they reside. This diversity, however, is even more 
dramatic than the genetic message may initially predict. 
As summarized in an excellent review by Wash and co-authors, (Walsh et al., 2005), Nature 
has devised two mechanisms of ‘proteome diversification’ over the course of evolution. The 
amount of unique proteins per unit RNA transcript has been dramatically amplified to be 
far more diverse than Central Dogma of protein expression would have suggested. The first 
method lies at the level of the transcript. Alternate splicing of the same gene product can 
result in a variety of unique proteins with unique functions. The second is through targeted 
post-translational modification of existing proteins and peptides to chemically ‘tag’ them. 
These “tags” can directly influence the structure and function of the protein, or it may be 
interpreted by another docking small molecule, protein, or assembly of proteins as a 
biological ON/OFF switch. This largely reversible labelling offers the ability to tune and 
coordinate signalling networks on a timescale faster than is required for protein synthesis 
and proteolysis. A necessity for life, it is not surprising that many aspects of signalling 
cascades predate species divergence from unicellular organisms. (Tan, 2011)  
While Nature has found a way to amplify the diversity of the pool of amino acid building 
blocks (in direct analogy to the diversification of DNA messages through arrangement of the 
nucleotide code), the selection pressures of evolution have still adhered to chemical intuition 
and energy conservation. In fact, evolution exerts less pressure on similar chemically 
structured residues. It seems the idea of a structural mimic is, ironically, bio-inspired.  
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2.2 Post-translational modification offers fast and dynamic response to stimulus 
Post-translational modification of proteins offers another layer of complexity in the 
regulation of cellular processes. It provides a powerful tool for fast and reversible 
modification of protein structure, which effects dynamic changes in protein function, and 
ultimately translates into a cellular phenotype. The most easily deciphered systems are those 
in which there is a large chemical difference between the modified and non-modified group 
and systems that are controlled by a unimodal ‘adding’ or ‘removing’ of an effector moiety, 
as in the prototypical case of phosphorylation (i.e., addition or removal of a phosphate 
group with a kinase or phosphatase, respectively). Chemical modification of an amino acid 
residue on an existing polypeptide is an energy-efficient means of reversibly and quickly 
altering the charge or steric properties of a peptide to result in a new molecular phenotype.  
For example, a mere phosphorylation event induces a large structural change in the bacterial 
receiver domain of the nitrogen regulatory protein C (NtrC) (Kern et al., 1999) (Fig. 1). 
Phosphorylation of NtrC at this position Asp54 causes the movement of three alpha-helices, 
resulting in the formation of a hydrophobic patch thought to be necessary for downstream 
signal transduction. 
 
Fig. 1. Phosphorylation induces conformational changes. Crystal structure of NtrC before 
(blue) and after (orange) phosphorylation of Asp54. A single residue modification from 
Asp54 (blue sticks) to the phosphorylated form (red sticks) results in major protein 
restructuring, including movement of -helix 4 (black arrows) away from the active site to 
generate a hydrophobic patch. Structural coordinates were obtained from the Protein 
Databank PDB code: (1DC7, 1DC8). 
To date, over 200 post-translation modifications have been identified; and they have been 
explored to varying extents, based on a mixture of propensity and technical accessibility. 
Phosphorylation, although overshadowed in propensity by glycosylation, is by far the most 
largely studied and characterized modification in the context of a signal relay in cellular 
systems. This is owed in large part to the availability of tools to efficiently mimic the 
isostructural property of phosphorylated residues, not the least of which is site-directed 
mutagenesis and the use of natural amino acids as constitutive substitutes.  
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2.3 Natural amino acids as substitutes for modified amino acids 
Invention of site-directed mutagenesis offered scientists, for the first time, access to the 
entire amino acid regimen for a given residue location. Chemical similarity between certain 
post-translationally modified residues and some natural amino acids became central to the 
field of genetic-based manipulation of protein properties. Shown in Fig. 2 are examples of 
natural mimics of some well-studied post-translational modifications, highlighting 
structural similarities.  
 
Fig. 2. Isostructural similarities between natural amino acids and post-translational 
modifications. Structural coordinates for natural amino acids and products of (A) 
phosphorylation (B), sulfoxidation, and (C) nitrosylation. Carbon atoms are shown in cyan; 
oxygen, in red; nitrogen, in blue; and phosphorous in gold. Hydrogen atoms have been 
omitted for clarity. 
While site-directed mutagenesis was first described in 1978 (Hutchison et al., 1978), the first 
examples of a PTM mimicking appeared in 1988 and 1989; the latter was described four 
years before the Nobel Prize in Chemistry was awarded to Michael Smith and Kary B. 
Mullis, for the development of site-directed mutagenesis and the polymerase chain reaction, 
respectively. When investigating the effect of phosphorylation of the large T antigen portion 
of Simian Virus 40 (SV40) on DNA-binding and replication, it was found that substitution of 
a known phosphorylatable Thr124 residue by glutamic acid, as opposed to alanine or 
cysteine, resulted in partial retention of native DNA replication activity. (Schneider et al., 
1988) It was suggested that a negative charge, and not a phospho-group per-se, was required 
to promote DNA replication. Shortly thereafter, two papers revealed a remarkable structural 
and functional similarity between the phosphorylated form of serine and glutamic acid. In 
agreement with similar structural deviations of phosphorylated serine and glutamic acid, 
the substitution of the regulatory Ser46 for glutamic acid in HPr (Wittekind et al., 1989), a 
protein component of the bacterial PEP-dependent sugar-transport system, resulted in 
enzyme inactivation indistinguishable from the native phosphorylation. (Reizer et al., 1989) 
The crystal structure of unmodified and phospho-Ser46 would later be determined (Jia et al, 
1994) (Audette et al., 2000), and an image of the electrostatic potential shows the large 
surface change that accompanies phosphorylation (Figure 3). 
This provided the first direct evidence for the structural mimicking of a phosphate group 
using site-directed mutagenesis. It showed that an easily genetically encoded glutamic acid 
residue was a strong phosphoserine mimic. The result was an explosion in the usage of 
point mutations as surrogates for phosphorylated or phospho-defective forms of potential 
regulatory sites. 
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Fig. 3. Phosphorylation induces marked structural and surface-contour changes. (Top) 
Ribbon diagrams of crystal structures of native and phosophorylated forms of HPr; Ser46 is 
highlighted in yellow, and nearby residues are shown. (Bottom) Surface representation of 
the wild-type and the phosphomimetic Asp55E variants of Hydrogen Uptake Protein 
Regulator (HupR). A phosphomimetic mutation induced marked surface-contour changes 
that affected protein dimerization and function. Structural coordinates were obtained from 
the Protein Databank (PDB code: 1FU0, 1PTF, 2JK1, 2VUH). Highlighted residues and the 
surface layer proximal to residue 55 in HupR were color-coded by atom type: carbon atoms 
are cyan, nitrogen atoms are blue, oxygen atoms are red, and phosphorous atoms are green 
(inhibitor compound). 
Another example of how substitution with phospho-mimetic glutamic acid can lead to a 
conformational change is shown in Fig. 3 (bottom). A surface-contour map of the receiver 
domain of nitrogen regulatory protein HupR (in which phosphorylation is actually 
inhibitory to transcription) before and after mutation of Asp55 to glutamic acid (Davies et al., 
2009) illustrates a marked surface change due to mutation of a single residue, which leads to 
deactivation of the receiver domain in a manner similar to that observed for authentic 
phosphorylation.  
Phosphorylation is not the only form of post-translation regulation that has been 
investigated with natural amino acid mimics. Biomimetic point mutations have been 
fundamental for studying some other means of protein modification including 
sulfoxidation, S-nitrosylation, tyrosine nitration, acetylation, methylation, etc. Several 
examples are illustrated in Table 1.  
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Modification Protein Substitution Readout Ref 
Phosphorylation CLIP-170 
SerAla 
SerGlu 
Co-immunoprecipitation, 
protein kinetics at MT tip 
(Lee et al., 
2010) 
 
Inositol 1,4,5- 
Trisphosphate 
Receptor (InsP3R) 
SerAla 
SerGlu Ca+2 release from ER  
(Wagner et al., 
2004) 
 
AMPA (GluA2 
subunit) 
SerAla 
SerGlu Conductance 
(Kristensen et 
al., 2011) 
 
Itch (E3-Ubiquitin 
Ligase) 
SerAla 
SerGlu 
ThrAla 
ThrGlu 
Co-immunoprecipitation 
/Proteolysis/  
Ubiquitinylation activity  
(Gallagher et 
al., 2006) 
Sulfinic acid Peroxiredoxin CysGlu Crystallography (Jonsson et al., 
2009) 
Sulfoxidation Slo-1 
MetLeu 
MetGlu 
Ionic current  
(Inside-out patch clamp) 
(Santarelli et 
al., 2006) 
Acetylation 
Heat shock protein- 
(HSP-90) 
LysArg 
LysGln 
CysAla 
Chaperon activity 
(Scroggins et 
al., 2007) 
S-nitrosylation Syntaxin-1 
CysSer 
CysTrp 
CysMet 
Exocytosis (amperometry) 
(Palmer et al., 
2008) 
 
Heat shock protein- 
(HSP-90) 
CysAla 
CysAsn 
CysAsp 
Protein dimerization (FRET) 
ATP-ase activity 
Reverse Transcriptase activity 
(Retzlaff et al., 
2009) 
Methylation 
Flap endonuclease 1 
(FEN1) 
ArgAla 
ArgPhe 
ArgLys 
Endonuclease activity 
(Guo et al., 
2010) 
Table 1. Representative post-translational modifications mimicked by natural point 
mutations using site-directed mutagenesis. 
Amino acid oxidation is a common mechanism for diversification of certain residues; and, like 
phosphorylation, there are both addition and removal effector proteins associated with the 
modification. The reactive sulfur group of the methionine residue can be oxidatively modified 
with a number of reagents to methionine sulfoxide or methionine sulfone, dramatically 
increasing the polarity and hydrophobicity of the residue. (Black and Mould, 1991) (Hoshi and 
Heinemann, 2001) A family of enzymes known as methionine sulfoxide reductases have been 
found competent to reduce the methionine sulfoxide back to a thioether, a necessary 
requirement for a signalling relay. Substitution of a leucine residue for methionine offers a 
suitably isostructural null mimic, removing the oxidizeable sulphur atom while maintaining 
similar geometric and hydrophobic characteristics. (Ciorba et al., 1997) (Chen et al., 2000) In 
one example, this modification, which adds electron density onto the long methionine residue, 
has been mimicked in vitro by glutamic acid substitution. Interestingly, it was recently found 
that calcium and voltage gated BK (Big Potassium) ion channels, responsible for regulating K+ 
ion flux, are sensitive to oxidation. This has been accomplished through lining of ion-selective 
pore with the hydrophobic Met536, Met712, and Met739 residues, which can be oxidatively 
modified to the more polar methionine sulfoxide, offering tuning of the hydrophobicity of 
channel. Oxidation of these methionine residues results in a decrease in half-activation voltage, 
increasing channel activity. Interestingly, one must mutate all three methionine residues 
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within the channel to leucine to render the channel insensitive to oxidant treatment. If, 
however, one replaces any one of these three residues with glutamic acid, the channel behaves 
just like it does in the wild-type protein after treatment with the oxidant. (Santarelli et al., 2006) 
Thus, the technique of site-directed mutagenesis revealed that any of the three separate 
methionine residues can confer the oxidant-sensitivity phenotype to the protein, highlighting a 
robust selection pressure for that function.  
Oxidized forms of cysteine, including nitrosyl, sulfenic acid, and sulfinic acid variants, have 
been implicated in reversible signalling arrays (Reddie and Carroll, 2008), and some have 
been mimicked with the use of natural amino acids. For example, cysteine sulfinic acid 
differs from aspartic acid by a single-atom replacement of sulphur atom with a carbon atom. 
This phosphomimicking strategy has been used in the investigation of the mechanism of 
peroxiredoxin (Pxr) (Jonsson et al., 2009), an enzyme involved in the ATP-dependent 
reduction of cysteine sulfinic acid back to a thiol residue. Reduction of an active site 
cysteine-sulfinic acid is first accomplished through ATP-dependent phospho-deficient of the 
sulfinic acid residue, followed by attack of a neighboring cysteine from sulfiredoxin (Srx) 
enzyme on the sulfinic phosphory ester intermediate. Remarkably, replacement of the 
catalytic cysteine in Pxr with an aspartic acid residue results in phosphorylation of the 
aspartic acid, but does not allow subsequent reactivity with the docked Srx. Thus, the single-
atom replacement offered by native site-directed mutagenesis allowed for detailed 
mechanistic study of a trapped intermediate complex, inaccessible with other techniques. 
Substitution of a cysteine residue with a serine residue offers an effective single-atom 
replacement of a sulphur atom with an oxygen atom and eliminates sulphur-based 
chemistry from the site, while minimizing steric differences.   
In several cases, tryptophan was reported to be an effective mimic of nitroso-cysteine 
(Palmer et al., 2008) (Wang et al., 2009) as computer simulations of the cysteine to 
tryptophan mutant suggest it contains steric bulk not offered by the next closest steric 
match, methionine, despite the absence of a sulphur atom in the former. In another case, 
nitroso-cysteine modification was mimicked by substitution with asparagine in studies 
investigating the effect of nitrosylation on ATPase activity of the 90 kDa heat shock protein 
(HSP90). (Retzlaff et al., 2009) (Scroggins and Neckers, 2009) In this study an NO-
insensitive HSP90 was rendered sensitive to inactivation by NO treatment due to 
replacement of an alanine residue in the C-terminal domain with a cysteine, as this 
corresponding site is known to be a cysteine in all other HSP variants. Mutation of the 
engineered site to asparagine (HSP90 A577N) recapitulates NO treatment of the engineered 
cysteine mutant, in contrast to a control isoleucine mutant (HSP90 A577I), which serves as 
an unmodifiable mimick (shown in Fig 4). Although no citation or rationale was used for the 
mutant choices, these mimicking residues indeed recapitulated ATPase activity and 
chaperone activity of the NO-free and NO-bound forms of engineered HSP90 protein. 
As virtually every intracellular process is under dynamic regulation, it is no surprise that 
PTM-mimicking mutations have been used in conjunction with a myriad of analytical 
techniques. Shown in Table 1 are some of examples relevant to native site-directed 
mutagenesis - giving a flavour of the breadth of the strategy. In a manuscript that would 
bring the strategies of the last nearly 35 years full circle, it has recently been suggested that 
throughout evolution, phosphoserine residues on proteins have been mutated, through 
genetic drift. In one study they were more frequently converted into glutamic acid and  
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Fig. 4. Mimicking S-nitrosylation in an engineered regulatory site. Ribbon representation of 
X-ray crystal structure of the Yeast HSP90 dimer; native Ala 577 (left) and engineered 
variants at position 577 (right) are highlighted in red. Note that there are structural 
similarities between cysteine and the non-modifiable isoleucine and between S-
nitrosocysteine and arginine. Structural coordinates were obtained from the Protein 
Databank (PDB code: 2CG9) Stick-models of residues were color-coded by atom type: 
carbon atoms are cyan, nitrogen atoms are blue, and oxygen atoms are red. 
aspartic acid than into any other residue, demonstrating evolution away from the switchable 
into permanent ON or OFF functions. (Kurmangaliyev et al., 2011) Although this work 
focused on non-structured regions and solely on phosphoserine evolution (the only post-
translational modification for which there were sufficient data sets for statistical 
interpretation), these results might be viewed as an acknowledgement from biology of a 
mere requirement for a well-placed charge to induce the biological phenotype for which the 
switch evolved.  
2.4 Site-directed mutagenesis in animal models 
The ultimate verification of the experimental models obtained in in vitro assays or even in 
cultured cells comes with experiments in living organisms. Site-directed mutagenesis, in 
combination with other technologies for delivering a tailored plasmid to more complex 
genomes, has allowed the knock-in of mutations for individual engineered proteins in entire 
organisms, including mammals. (Yang et al., 1997) This technology has been used to 
investigate the role of individual amino acids in many biological processes and disease 
states, such as ASD (Autism Spectrum Disorder) (Bader et al., 2011), malignant 
hyperthermia (associated with heat stroke susceptibility) (Durham et al., 2008), and 
depression (Talbot et al., 2010), in the context of a living mammals. Phosphomimetic and 
phospho-deficient mutations have been knocked-in as well, leading to new understanding 
of downstream events to protein modification in the context of a living organism. In one 
prominent example, phosphorylation of ribosomal protein S6 was linked to control of cell 
size and glucose homeostasis in certain cell types through the use of a phospho-deficient 
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knock-in mouse model. (Ruvinsky et al., 2005) In this model, all five potentially 
phosphorylatable serine residues in the putative region of rS6 were mutated to alanine 
(rpS6P−/−) to abolish the potential for their phosphorylation. Smaller cell size, increased 
protein synthesis, and a severe decrease of circulating insulin were among the phenotypic 
signatures of the phospho-deficient variant. The phenotype was later shown to include 
decreased muscle mass and energy availability. 
In another salient example, both phosphomimetic and phospho-deficient mutations were 
generated in a transgenic mouse model of Huntington’s disease - a neurodegenerative 
disorder characterized by motor impairments and various psychiatric symptoms. (Gu et al., 
2009) In this model, two phosphorylatable serine residues (13 and 18) in the N-terminus of a 
disease-promoting mutant of the huntingtin protein (mhtt) were mutated to either glutamate 
(phosphomimetic) or alanine (phospho-deficient) residues to investigate effect of 
phosphorylation on modification of the htt protein with a polyglutamine (PolyQ) extension, 
and on the onset of Huntington’s Disease. Both mutants were viable and successfully 
rescued the embryonic lethality of an htt knockout mutant. A remarkable difference was 
observed between the Ala and Glu variants. The mice that were phosphodeficient (Ala) in 
the two serine residues showed onset of disease pathogenesis from the mutant mhtt - as 
measured by neuropathological examination of brain tissue sections, as well as by various 
motor and psychological tests. Remarkably, the phosphomimetic mutant mice (Glu) showed 
resistance to mhtt-induced disease pathogenesis. This technique clearly demonstrated that 
loss–of-phosphorylation of these two serine sites is a key signature of the pathogenesis in 
vivo. These results further suggested that the N-terminus of htt may be a target for future 
drug design to treat disease, even after the initializing mutation is present. 
Indeed these examples show the power of site-directed mutagenesis in studying the 
signaling events associated with the disease state. However, caution must always be taken 
in the interpretation of data obtained from studies using biomimetic constructs. 
2.5 Limitations of site-directed mutagenesis for targeting signaling nodes  
Despite vast precedent for the utilization of amino acid surrogates and mimics of post-
translational modifications in the literature, it must be remembered that the data and 
interpretation are only as robust as the chemical match of the surrogate moiety to the target. 
For example, the carboxylic acid functionality of glutamic acid has differing fundamental 
chemical properties from a serine-phosphate group, including, but not limited to, access to a 
(-2) charge state (in the case of phosphate) and different acid dissociation constants. Despite 
this, the single mutation has proven a valuable tool in the mimicking of phosphorylated 
residues. In addition it has become a common and quite inexpensive laboratory procedure, 
which is qualified as a ‘quick-check’ protocol to produce constitutively active, inactive or 
null mutants of potential phosphorylation sites. 
As mentioned, PTMs that result in a significant size or charge difference from the 
unmodified states have been among the earliest developed. For example, while 
phosphorylation is the most thoroughly studied form of modification, it has been predicted 
that protein methylation will be among the slowest developed signalling pathways. This is 
due to the subtle spatial and charge density differences between methylated and non-
methylated forms of an amino acid residue. With mass spectrometry virtually alone in the 
struggle to address such modifications, the decoding of such signalling networks awaits the 
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development of sufficient chemical tools to recognize such subtle nodes and expedite 
interpretation and clarification of mass spectral data. (Huttlin et al., 2010) 
It is probable that certain interactions, or classes of interactions, may be more stringent in 
which the electronic features of post-translationally modified residues are recognized and 
interpreted as signals. The importance of a cautious eye when utilizing signalling mimics 
was recently made salient when a phosphometic serine to glutamic acid mutant 
recapitulated one aspect of a signalling cascade, but not another. (Paleologou et al., 2010) 
While investigating potential phosphorylation sites in -synuclein - a major component of 
the Alzheimer’s disease amyloid - the authors generated serine to glutamate and serine to 
alanine mutants and compared them to wild-type and authentic phosphorylated material in 
ability to localize at the membrane and participate in fibril formation. In a model wherein 
phosphorylation of Ser87 blocks membrane recruitment and fibril formation, it was shown 
that substitution of native Ser87 with alanine resulted in wild-type-like membrane 
association and fibril formation, while authentic phospho-Ser87, along with the Ser87E 
mutant, showed blunted formation of fibrils and poor membrane recruitment. Circular 
dichroism studies showed that, in a micellar environment, the authentic phospho-Ser87 
modification resulted in an unstructuring of the random coiled protein, whereas the 
phosphomimic mutant could not recapitulate the membrane-associate phenotype. This 
unstructuring has been shown to be important in the interaction with membrane contents, 
and may further alter protein specificity. Thus, the phosphomimetic mutation introduced 
with site-directed mutagenesis could only reproduce one aspect of the biological phenotype. 
In this case, the authors were able to view the limits of the phosphomimic approach because 
they had access to constructs containing the authentic phosphoprotein for comparison. 
Nevertheless, it serves as an instructive case in which it is acknowledged that a given PTM 
can have multiple roles or be required in multiple steps of a signalling cascade or pathway. 
3. Conclusion 
We have demonstrated that site-directed mutagenesis has played an indispensable role in the 
unravelling of signal transduction pathways by offering access to constitutively active or 
inactive forms of several common PTMs. A critical eye must be used when utilizing surrogate 
residues that lack the capacity for a switchable context, and it is important to understand the 
limits of any biomimetic approach before results can be properly interpreted. Even with these 
limitations, it is no wonder the technique of site-directed mutagenesis has penetrated the field 
of signal transduction since the very conception of the technology. Indeed the utility of site-
directed mutagenesis for the development and verification of models for biological processes 
and disease states will remain beneficial for years to come. 
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